Keryx Biopharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsKeryx Biopharmaceuticals

Keryx Biopharmaceuticals(KERX)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Auryxia	Ferric pyrophosphate citrate	2014-09-05		—

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

diabetic nephropathies

,

kidney diseases

,

brain neoplasms

,

,

,

,

oligodendroglioma

,

diabetic nephropathies

,

kidney diseases

,

,

allergic rhinitis

,

,

allergic conjunctivitis

,

liver neoplasms

,

atopic dermatitis

,

,

neoplasm metastasis

,

healthy volunteers/patients

,

,

prostatic neoplasms

,

,

,

,

esophageal neoplasms

,

postoperative nausea and vomiting

,

soft tissue neoplasms

,

brain neoplasms

,

second primary neoplasms

,

treatment-resistant depressive disorder

,

esophageal squamous cell carcinoma

,

renal cell carcinoma

,

experimental liver cirrhosis

,

chronic obstructive pulmonary disease

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

,

,

colorectal neoplasms

,

pancreatic ductal carcinoma

,

biliary tract neoplasms

,

non-muscle invasive bladder neoplasms

,

non-small-cell lung carcinoma

,

,

,

,

ovarian neoplasms

,

uterine cervical neoplasms

,

triple negative breast neoplasms

,

breast neoplasms

,

condylomata acuminata

,

hepatocellular carcinoma

,

,

immunologic deficiency syndromes

,

,

antibiotic prophylaxis

,

,

chronic hepatitis b

,

ovarian epithelial carcinoma

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

,

,

cystic fibrosis

,

pulmonary hypertension

,

pulmonary arterial hypertension

,

endometrial neoplasms

,

fallopian tube neoplasms

,

urinary bladder neoplasms

,

acquired immunodeficiency syndrome

,

,

chronic hepatitis c

,

,

,

,

,

neuromuscular blockade

,

hematologic neoplasms

,

hematopoietic stem cell transplantation

,

,

pseudomonas infections

,

pseudomonas aeruginosa

,

gram-negative bacterial infections

,

,

chronic kidney failure

,

kidney diseases

,

chronic hepatitis

,

intestinal diseases

,

,

non-hodgkin lymphoma

,

,

,

traumatic brain injuries

,

brain concussion

,

,

post-concussion syndrome

,

papillomavirus infections

,

uterine cervical dysplasia

chronic kidney failure

inflammatory breast neoplasms

,

paraneoplastic syndromes

,

ovarian neoplasms

,

esophageal neoplasms

,

,

,

pancreatic neoplasms

,

ovarian epithelial carcinoma

,

nasopharyngeal neoplasms

,

endometrial neoplasms

,

fallopian tube neoplasms

,

squamous cell carcinoma of head and neck

,

germ cell and embryonal neoplasms

,

nasopharyngeal carcinoma

,

urinary bladder neoplasms

,

ductal carcinoma

,

male breast neoplasms

,

,

triple negative breast neoplasms

,

peritoneal neoplasms

,

,

hepatocellular carcinoma

,

liver neoplasms

,

residual neoplasm

,

mouth neoplasms

,

gastrointestinal diseases

,

testicular neoplasms

,

uterine neoplasms

,

endometrioid carcinoma

,

breast neoplasms

,

,

stomach neoplasms

,

neoplasm metastasis

,

squamous cell neoplasms

,

squamous cell carcinoma

,

,

laryngeal neoplasms

,

local neoplasm recurrence

,

hypopharyngeal neoplasms

,

lobular carcinoma

,

ductal carcinoma breast

,

brain stem neoplasms

,

castration-resistant prostatic neoplasms

,

prostatic neoplasms

,

non-small-cell lung carcinoma

,

,

head and neck neoplasms

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use